Biotechnology
The Biotechnology industry has a total of 596 stocks, with a combined market cap of $1.1 trillion and total revenue of $110.49 billion.
Market Cap
1.1T
Revenue
110.49B
Profits
-40.67B
PE Ratio
n/a
Profit Margin
-36.81%
Dividend Yield
0.04%
596 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.06B | -3.57% | 1,108,627 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.50B | -2.87% | 655,176 | 14.34B |
| 3 | ARGX | argenx SE | 44.30B | -2.86% | 413,570 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.51B | -2.07% | 1,214,536 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 32.50B | -2.03% | 303,050 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.95B | -4.21% | 2,267,911 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.35B | -3.69% | 3,384,577 | 2.38B |
| 8 | BNTX | BioNTech SE | 25.58B | -1.78% | 693,127 | 3.70B |
| 9 | ROIV | Roivant Sciences Ltd. | 21.27B | 0.68% | 9,168,648 | 13.31M |
| 10 | MRNA | Moderna, Inc. | 21.26B | -6.87% | 13,934,911 | 1.94B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.75B | -1.53% | 1,704,207 | - |
| 12 | INCY | Incyte Corporation | 19.37B | -1.55% | 1,330,288 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.89B | -2.48% | 1,361,066 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.57B | -1.67% | 478,428 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 12.83B | -0.56% | 1,783,786 | 502.08M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.42B | -5.40% | 2,727,659 | 943.71M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 11.65B | 0.23% | 2,245,609 | 3.22B |
| 18 | SMMT | Summit Therapeutics Inc. | 11.58B | -2.86% | 2,431,220 | - |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.30B | -2.68% | 599,570 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.72B | -0.98% | 3,438,711 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.08B | 1.04% | 275,373 | 958.40M |
| 22 | IBRX | ImmunityBio, Inc. | 9.21B | -0.44% | 19,259,380 | 113.29M |
| 23 | ABVX | ABIVAX Société Anonyme | 8.92B | -3.49% | 592,930 | 6.23M |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.91B | -2.30% | 2,540,375 | 1.09B |
| 25 | TECH | Bio-Techne Corporation | 8.74B | -3.39% | 2,482,037 | 1.22B |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 8.65B | -4.47% | 388,663 | 7.46M |
| 27 | PCVX | Vaxcyte, Inc. | 8.38B | -3.13% | 1,081,112 | - |
| 28 | AXSM | Axsome Therapeutics, Inc. | 8.26B | -1.60% | 495,950 | 638.50M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 7.95B | -3.80% | 1,879,175 | 1.40B |
| 30 | NUVL | Nuvalent, Inc. | 7.87B | -2.47% | 601,757 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.66B | -0.13% | 1,281,231 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.61B | -1.76% | 221,486 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.82B | -3.01% | 1,044,442 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.69B | 0.05% | 1,674,229 | 22.29M |
| 35 | BLTE | Belite Bio, Inc | 6.53B | -2.14% | 129,634 | - |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.25B | 0.51% | 661,337 | 189.76M |
| 37 | COGT | Cogent Biosciences, Inc. | 6.03B | 1.19% | 2,385,326 | - |
| 38 | PTGX | Protagonist Therapeutics, Inc. | 5.83B | -3.61% | 459,828 | 46.02M |
| 39 | CRSP | CRISPR Therapeutics AG | 5.50B | -4.45% | 1,539,829 | 3.51M |
| 40 | IMVT | Immunovant, Inc. | 5.44B | -1.33% | 1,124,028 | - |
| 41 | CAI | Caris Life Sciences, Inc. | 5.43B | -3.22% | 1,726,072 | 812.03M |
| 42 | CELC | Celcuity Inc. | 5.33B | 2.73% | 765,147 | - |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.30B | -2.70% | 1,561,423 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.30B | -5.59% | 1,584,511 | 521.31M |
| 45 | PTCT | PTC Therapeutics, Inc. | 5.24B | -1.49% | 918,167 | 1.73B |
| 46 | CGON | CG Oncology, Inc. | 5.10B | -1.95% | 1,535,063 | 4.04M |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.88B | -1.92% | 972,649 | - |
| 48 | ERAS | Erasca, Inc. | 4.81B | 2.78% | 5,481,393 | - |
| 49 | TERN | Terns Pharmaceuticals, Inc. | 4.57B | -1.25% | 1,453,768 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.50B | - | 4,467,780 | 634.21M |
| 51 | TGTX | TG Therapeutics, Inc. | 4.29B | -0.55% | 2,003,521 | 616.29M |
| 52 | GPCR | Structure Therapeutics Inc. | 4.23B | -5.43% | 803,088 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.11B | -1.28% | 260,155 | 268.09M |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.07B | -1.54% | 948,747 | 7.70M |
| 55 | CNTA | Centessa Pharmaceuticals plc | 3.85B | -1.35% | 2,995,904 | 15.00M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 3.82B | -4.23% | 2,208,984 | 1.07B |
| 57 | ADMA | ADMA Biologics, Inc. | 3.74B | -5.08% | 4,009,698 | 510.17M |
| 58 | VKTX | Viking Therapeutics, Inc. | 3.64B | -1.96% | 3,140,646 | - |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.62B | -4.62% | 1,330,167 | 761.41M |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 3.49B | -2.60% | 814,444 | 7.50M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.47B | -3.34% | 1,335,304 | 22.50M |
| 62 | ALMS | Alumis Inc. | 3.45B | -4.26% | 1,301,161 | 22.12M |
| 63 | LEGN | Legend Biotech Corporation | 3.28B | -0.56% | 1,655,327 | 909.05M |
| 64 | SYRE | Spyre Therapeutics, Inc. | 3.19B | -1.00% | 526,844 | - |
| 65 | TARS | Tarsus Pharmaceuticals, Inc. | 3.19B | -1.71% | 319,196 | 451.36M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.12B | -3.29% | 1,168,587 | - |
| 67 | EWTX | Edgewise Therapeutics, Inc. | 3.05B | -1.70% | 922,858 | - |
| 68 | LQDA | Liquidia Corporation | 3.00B | 0.41% | 2,385,082 | 158.32M |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 2.97B | -0.62% | 1,241,427 | 376.07M |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.97B | -1.50% | 1,731,568 | 588.99M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.96B | -4.71% | 1,389,118 | 70.85M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 2.90B | -4.76% | 493,308 | 218.71M |
| 73 | RCUS | Arcus Biosciences, Inc. | 2.78B | -2.07% | 1,160,408 | 247.00M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.77B | -2.02% | 864,106 | - |
| 75 | DNTH | Dianthus Therapeutics, Inc. | 2.66B | -0.92% | 940,765 | 3.08M |
| 76 | APLS | Apellis Pharmaceuticals, Inc. | 2.58B | 1.46% | 2,925,769 | 1.00B |
| 77 | BEAM | Beam Therapeutics Inc. | 2.53B | -7.00% | 2,090,013 | 139.74M |
| 78 | TVTX | Travere Therapeutics, Inc. | 2.52B | -3.09% | 832,177 | 490.73M |
| 79 | DYN | Dyne Therapeutics, Inc. | 2.51B | -0.20% | 1,993,682 | - |
| 80 | WVE | Wave Life Sciences Ltd. | 2.48B | -3.72% | 3,053,949 | 42.73M |
| 81 | ADPT | Adaptive Biotechnologies Corporation | 2.45B | -3.10% | 1,850,816 | 276.98M |
| 82 | TLX | Telix Pharmaceuticals Limited | 2.39B | 3.78% | 570,624 | 803.79M |
| 83 | IMNM | Immunome, Inc. | 2.37B | -6.97% | 2,002,564 | 6.94M |
| 84 | IRON | Disc Medicine, Inc. | 2.30B | -1.24% | 833,339 | - |
| 85 | TNGX | Tango Therapeutics, Inc. | 2.27B | 36.28% | 17,986,518 | 62.38M |
| 86 | OCUL | Ocular Therapeutix, Inc. | 2.25B | -6.43% | 7,384,683 | 51.95M |
| 87 | GLPG | Galapagos NV | 2.20B | -0.92% | 180,619 | 1.31B |
| 88 | MAZE | Maze Therapeutics, Inc. | 2.18B | -2.54% | 349,941 | 2.50M |
| 89 | ZLAB | Zai Lab Limited | 2.16B | 0.16% | 999,245 | 460.16M |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.11B | -7.13% | 1,270,830 | - |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.07B | -1.56% | 2,063,304 | 673.00M |
| 92 | AAPG | Ascentage Pharma Group International | 2.05B | -0.22% | 837 | 54.52M |
| 93 | NKTR | Nektar Therapeutics | 2.03B | 1.88% | 757,923 | 62.60M |
| 94 | SLNO | Soleno Therapeutics, Inc. | 1.99B | 1.15% | 1,690,074 | 190.41M |
| 95 | STOK | Stoke Therapeutics, Inc. | 1.98B | 0.67% | 769,838 | 205.63M |
| 96 | MESO | Mesoblast Limited | 1.97B | 7.54% | 644,297 | 65.38M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -1.99% | 1,619,841 | 283.06M |
| 98 | CLDX | Celldex Therapeutics, Inc. | 1.95B | -0.61% | 611,281 | 1.55M |
| 99 | SNDX | Syndax Pharmaceuticals, Inc. | 1.90B | -0.19% | 817,770 | 172.35M |
| 100 | IOVA | Iovance Biotherapeutics, Inc. | 1.89B | 7.51% | 23,514,268 | 263.50M |
| 101 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | -2.75% | 12,740,419 | 74.68M |
| 102 | TYRA | Tyra Biosciences, Inc. | 1.86B | -2.07% | 1,780,096 | - |
| 103 | ZYME | Zymeworks Inc. | 1.83B | -1.70% | 804,169 | 105.97M |
| 104 | MANE | Veradermics, Incorporated | 1.82B | 2.68% | 153,030 | - |
| 105 | PVLA | Palvella Therapeutics, Inc. | 1.81B | -0.40% | 243,386 | - |
| 106 | OLMA | Olema Pharmaceuticals, Inc. | 1.77B | -7.31% | 1,541,103 | - |
| 107 | ELVN | Enliven Therapeutics, Inc. | 1.75B | -2.30% | 754,708 | - |
| 108 | DFTX | Definium Therapeutics, Inc. | 1.75B | -1.18% | 1,984,962 | - |
| 109 | VCEL | Vericel Corporation | 1.73B | -2.75% | 352,751 | 276.26M |
| 110 | RLAY | Relay Therapeutics, Inc. | 1.72B | -5.02% | 1,656,026 | 15.36M |
| 111 | GLTO | Galecto, Inc. | 1.71B | -4.45% | 247,794 | - |
| 112 | SRPT | Sarepta Therapeutics, Inc. | 1.70B | 0.87% | 2,486,315 | 2.20B |
| 113 | PHVS | Pharvaris N.V. | 1.68B | -3.53% | 125,044 | - |
| 114 | TRVI | Trevi Therapeutics, Inc. | 1.68B | 1.24% | 1,462,579 | - |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.65B | -0.11% | 1,085,491 | 868.45M |
| 116 | ANAB | AnaptysBio, Inc. | 1.65B | -5.40% | 951,286 | 234.60M |
| 117 | INVA | Innoviva, Inc. | 1.64B | -2.42% | 707,433 | 411.33M |
| 118 | OCS | Oculis Holding AG | 1.63B | 0.07% | 417,201 | 1.51M |
| 119 | NVAX | Novavax, Inc. | 1.63B | 1.01% | 4,014,645 | 1.12B |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -1.81% | 1,020,374 | 54.03M |
| 121 | IMCR | Immunocore Holdings plc | 1.62B | -5.19% | 559,489 | 400.02M |
| 122 | NBTX | Nanobiotix S.A. | 1.62B | -6.14% | 50,830 | 11.93M |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.61B | -5.20% | 367,462 | - |
| 124 | GENB | Generate Biomedicines, Inc. | 1.59B | 7.51% | 1,041,777 | 31.89M |
| 125 | NUVB | Nuvation Bio Inc. | 1.57B | -3.59% | 8,347,721 | 62.90M |
| 126 | NRIX | Nurix Therapeutics, Inc. | 1.57B | -6.40% | 1,096,361 | 83.98M |
| 127 | KOD | Kodiak Sciences Inc. | 1.56B | -6.26% | 388,452 | - |
| 128 | SION | Sionna Therapeutics, Inc. | 1.56B | -0.03% | 611,706 | - |
| 129 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -4.85% | 4,286,446 | 67.67M |
| 130 | BHVN | Biohaven Ltd. | 1.55B | -2.83% | 2,333,760 | - |
| 131 | ARDX | Ardelyx, Inc. | 1.54B | -5.71% | 3,562,292 | 407.32M |
| 132 | MBX | MBX Biosciences, Inc. | 1.48B | 0.40% | 550,115 | - |
| 133 | VIR | Vir Biotechnology, Inc. | 1.45B | -4.81% | 2,097,431 | 68.56M |
| 134 | GLUE | Monte Rosa Therapeutics, Inc. | 1.42B | -3.55% | 1,179,258 | 181.54M |
| 135 | RAPP | Rapport Therapeutics, Inc. | 1.41B | 1.06% | 316,322 | - |
| 136 | ORIC | ORIC Pharmaceuticals, Inc. | 1.39B | 2.52% | 1,671,470 | - |
| 137 | IMTX | Immatics N.V. | 1.36B | -0.29% | 237,278 | 56.67M |
| 138 | SVRA | Savara Inc. | 1.36B | -2.31% | 1,260,701 | - |
| 139 | ZBIO | Zenas BioPharma, Inc. | 1.36B | -2.17% | 314,778 | 15.00M |
| 140 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | -9.98% | 1,143,707 | - |
| 141 | CAPR | Capricor Therapeutics, Inc. | 1.34B | 1.25% | 784,339 | 11.13M |
| 142 | DAWN | Day One Biopharmaceuticals, Inc. | 1.32B | -0.70% | 2,800,568 | 158.18M |
| 143 | EYPT | EyePoint, Inc. | 1.30B | -12.44% | 2,525,961 | 31.37M |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.29B | -0.66% | 762,191 | - |
| 145 | ATAI | AtaiBeckley Inc. | 1.29B | -4.07% | 4,851,952 | 3.02M |
| 146 | SEPN | Septerna, Inc. | 1.23B | -4.70% | 494,848 | 22.05M |
| 147 | TSHA | Taysha Gene Therapies, Inc. | 1.23B | -3.23% | 3,782,002 | 6.31M |
| 148 | BCAX | Bicara Therapeutics Inc. | 1.20B | -0.22% | 950,182 | - |
| 149 | DBVT | DBV Technologies S.A. | 1.20B | -3.12% | 276,092 | 5.50M |
| 150 | PGEN | Precigen, Inc. | 1.19B | -5.07% | 4,995,424 | 6.31M |
| 151 | IVA | Inventiva S.A. | 1.17B | 0.50% | 345,382 | 19.93M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.09B | -1.10% | 2,248,366 | 75.13M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.08B | -1.49% | 189,392 | 5.56M |
| 154 | PHAR | Pharming Group N.V. | 1.07B | -3.02% | 19,808 | 362.27M |
| 155 | AVBP | ArriVent BioPharma, Inc. | 1.04B | -4.93% | 598,140 | - |
| 156 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | -0.49% | 2,370,120 | 291.85M |
| 157 | INBX | Inhibrx Biosciences, Inc. | 1.03B | -5.32% | 179,545 | 1.40M |
| 158 | VTYX | Ventyx Biosciences, Inc. | 1.00B | - | - | - |
| 159 | CMPX | Compass Therapeutics, Inc. | 983.58M | -2.81% | 2,821,798 | 850.00K |
| 160 | URGN | UroGen Pharma Ltd. | 954.66M | -2.73% | 825,326 | 109.79M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 946.01M | -3.66% | 877,445 | 185.74M |
| 162 | VALN | Valneva SE | 943.91M | 1.28% | 13,758 | 211.09M |
| 163 | GHRS | GH Research PLC | 943.16M | -4.91% | 557,411 | - |
| 164 | FTRE | Fortrea Holdings Inc. | 927.52M | -4.43% | 1,423,308 | 2.72B |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 921.59M | -4.29% | 737,663 | - |
| 166 | SANA | Sana Biotechnology, Inc. | 910.02M | -10.73% | 3,491,697 | - |
| 167 | GERN | Geron Corporation | 909.57M | -3.40% | 17,895,036 | 183.88M |
| 168 | ABUS | Arbutus Biopharma Corporation | 903.92M | -1.05% | 2,545,280 | 14.61M |
| 169 | SPRY | ARS Pharmaceuticals, Inc. | 901.50M | 0.88% | 1,331,367 | 142.77M |
| 170 | SLS | SELLAS Life Sciences Group, Inc. | 899.09M | -4.69% | 7,376,022 | - |
| 171 | SGP | SpyGlass Pharma, Inc. | 880.25M | -0.97% | 90,294 | - |
| 172 | ARVN | Arvinas, Inc. | 877.54M | -0.29% | 1,051,881 | 262.60M |
| 173 | MNKD | MannKind Corporation | 871.92M | -4.07% | 6,296,695 | 348.97M |
| 174 | JANX | Janux Therapeutics, Inc. | 849.82M | -2.65% | 1,048,268 | 10.00M |
| 175 | PHAT | Phathom Pharmaceuticals, Inc. | 844.33M | -3.12% | 1,044,054 | 175.11M |
| 176 | KALV | KalVista Pharmaceuticals, Inc. | 819.36M | -0.98% | 638,670 | 1.43M |
| 177 | XNCR | Xencor, Inc. | 818.46M | -12.40% | 1,649,403 | 125.58M |
| 178 | OMER | Omeros Corporation | 814.65M | -0.86% | 808,529 | - |
| 179 | ANNX | Annexon, Inc. | 809.37M | -2.86% | 3,158,809 | - |
| 180 | CTMX | CytomX Therapeutics, Inc. | 808.21M | -5.92% | 2,404,498 | 113.63M |
| 181 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 791.09M | -1.97% | 157,083 | - |
| 182 | EVMN | Evommune, Inc. | 790.94M | 6.36% | 221,344 | 13.00M |
| 183 | EIKN | Eikon Therapeutics, Inc. | 784.93M | -4.09% | 223,903 | - |
| 184 | MPLT | MapLight Therapeutics, Inc. | 783.80M | -0.36% | 142,009 | - |
| 185 | DRUG | Bright Minds Biosciences Inc. | 775.15M | -1.90% | 147,717 | - |
| 186 | KURA | Kura Oncology, Inc. | 740.52M | -0.47% | 3,320,902 | 67.48M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 711.67M | -5.43% | 323,479 | 107.27M |
| 188 | PROK | ProKidney Corp. | 708.46M | -4.27% | 452,118 | 744.00K |
| 189 | MDXG | MiMedx Group, Inc. | 705.69M | -1.45% | 894,303 | 418.63M |
| 190 | LXRX | Lexicon Pharmaceuticals, Inc. | 700.42M | 0.61% | 4,084,129 | 49.80M |
| 191 | PRME | Prime Medicine, Inc. | 695.92M | -4.61% | 3,030,047 | 4.63M |
| 192 | AGMB | AgomAb Therapeutics NV | 692.55M | -3.20% | 75,207 | - |
| 193 | TBPH | Theravance Biopharma, Inc. | 688.13M | -0.62% | 1,292,019 | 80.33M |
| 194 | QURE | uniQure N.V. | 663.41M | 17.81% | 9,575,180 | 16.10M |
| 195 | ZURA | Zura Bio Limited | 641.36M | -3.29% | 522,779 | - |
| 196 | ANRO | Alto Neuroscience, Inc. | 639.35M | -3.97% | 149,942 | - |
| 197 | JBIO | Jade Biosciences, Inc. | 638.54M | -0.57% | 211,033 | - |
| 198 | DRTS | Alpha Tau Medical Ltd. | 607.08M | 1.42% | 250,219 | - |
| 199 | VOR | Vor Biopharma Inc. | 604.53M | -3.26% | 448,047 | - |
| 200 | LBRX | LB Pharmaceuticals Inc | 599.34M | -2.91% | 174,200 | - |
| 201 | YDES | YD Bio Limited | 589.17M | -0.85% | 15,030 | 510.36K |
| 202 | ENGN | enGene Holdings Inc. | 583.48M | -10.57% | 635,955 | - |
| 203 | REPL | Replimune Group, Inc. | 581.31M | -2.90% | 630,706 | - |
| 204 | DSGN | Design Therapeutics, Inc. | 574.76M | -2.70% | 269,923 | - |
| 205 | OCGN | Ocugen, Inc. | 570.53M | -11.22% | 8,089,555 | 4.41M |
| 206 | LRMR | Larimar Therapeutics, Inc. | 566.84M | -4.22% | 2,304,868 | - |
| 207 | MGTX | MeiraGTx Holdings plc | 560.62M | -6.01% | 955,371 | 27.42M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 544.96M | -0.44% | 715,504 | 294.28M |
| 209 | FBRX | Forte Biosciences, Inc. | 544.75M | -3.81% | 151,385 | - |
| 210 | FULC | Fulcrum Therapeutics, Inc. | 543.46M | -2.28% | 859,767 | 80.00M |
| 211 | VSTM | Verastem, Inc. | 540.19M | 5.85% | 2,681,042 | 30.91M |
| 212 | TECX | Tectonic Therapeutic, Inc. | 522.93M | 1.61% | 471,840 | - |
| 213 | ALLO | Allogene Therapeutics, Inc. | 519.13M | -8.70% | 4,706,889 | 22.00K |
| 214 | ADCT | ADC Therapeutics SA | 519.05M | -1.18% | 1,516,735 | 75.21M |
| 215 | PRTA | Prothena Corporation plc | 509.26M | -4.06% | 363,305 | 9.68M |
| 216 | NMRA | Neumora Therapeutics, Inc. | 506.42M | -2.30% | 810,217 | - |
| 217 | CTNM | Contineum Therapeutics, Inc. | 504.47M | -7.07% | 397,800 | - |
| 218 | RCKT | Rocket Pharmaceuticals, Inc. | 503.76M | -3.73% | 3,681,169 | - |
| 219 | CRMD | CorMedix Inc. | 496.37M | -11.52% | 4,213,747 | 311.71M |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 494.86M | -1.57% | 1,098,828 | 84.39M |
| 221 | LXEO | Lexeo Therapeutics, Inc. | 493.39M | -6.63% | 758,222 | - |
| 222 | EPRX | Eupraxia Pharmaceuticals Inc. | 493.18M | -2.69% | 108,857 | - |
| 223 | IVVD | Invivyd, Inc. | 490.66M | 1.75% | 2,680,365 | 53.43M |
| 224 | TENX | Tenax Therapeutics, Inc. | 480.35M | -0.92% | 264,847 | - |
| 225 | KYTX | Kyverna Therapeutics, Inc. | 479.32M | -5.41% | 546,909 | - |
| 226 | LYEL | Lyell Immunopharma, Inc. | 472.47M | -6.55% | 89,058 | 41.00K |
| 227 | VNDA | Vanda Pharmaceuticals Inc. | 467.54M | -3.54% | 967,975 | 216.11M |
| 228 | VTVT | vTv Therapeutics Inc. | 461.86M | 3.39% | 75,775 | 17.00K |
| 229 | IPSC | Century Therapeutics, Inc. | 459.90M | 5.35% | 1,946,699 | 113.34M |
| 230 | IMMX | Immix Biopharma, Inc. | 450.02M | -0.23% | 391,726 | - |
| 231 | LCTX | Lineage Cell Therapeutics, Inc. | 445.88M | -5.64% | 1,418,130 | 10.82M |
| 232 | RGNX | REGENXBIO Inc. | 441.43M | -4.60% | 1,356,577 | 170.44M |
| 233 | AVXL | Anavex Life Sciences Corp. | 441.12M | -4.80% | 1,085,714 | - |
| 234 | FDMT | 4D Molecular Therapeutics, Inc. | 440.71M | -3.25% | 672,338 | 120.00K |
| 235 | ALT | Altimmune, Inc. | 438.94M | -17.92% | 7,620,807 | 41.00K |
| 236 | ASMB | Assembly Biosciences, Inc. | 437.50M | -7.15% | 167,014 | 37.19M |
| 237 | SLDB | Solid Biosciences Inc. | 437.08M | -8.63% | 1,140,257 | - |
| 238 | NBP | NovaBridge Biosciences | 419.66M | 17.04% | 2,257,745 | - |
| 239 | TRDA | Entrada Therapeutics, Inc. | 419.04M | -6.88% | 407,550 | 25.42M |
| 240 | UPB | Upstream Bio, Inc. | 414.48M | -1.67% | 941,636 | 2.80M |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 414.07M | 6.43% | 1,441,403 | - |
| 242 | NAGE | Niagen Bioscience, Inc. | 409.26M | 3.24% | 4,197,134 | 129.42M |
| 243 | DMAC | DiaMedica Therapeutics Inc. | 406.66M | -2.32% | 206,049 | - |
| 244 | PRTC | PureTech Health plc | 400.74M | 0.53% | 1,099 | 6.39M |
| 245 | ARMP | Armata Pharmaceuticals, Inc. | 399.02M | -5.60% | 64,115 | 5.05M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 398.73M | -10.84% | 240,509 | 66.98M |
| 247 | DNA | Ginkgo Bioworks Holdings, Inc. | 398.14M | 2.24% | 951,779 | 170.16M |
| 248 | AUTL | Autolus Therapeutics plc | 395.22M | -8.90% | 1,842,179 | 51.13M |
| 249 | IMMP | Immutep Limited | 391.15M | 1.10% | 113,547 | 5.28M |
| 250 | ABSI | Absci Corporation | 389.46M | -2.63% | 2,980,359 | 2.82M |
| 251 | PEPG | PepGen Inc. | 378.46M | -18.57% | 3,246,923 | - |
| 252 | LENZ | LENZ Therapeutics, Inc. | 377.36M | -6.94% | 711,881 | 17.50M |
| 253 | CBIO | Crescent Biopharma, Inc. | 376.31M | -1.39% | 132,639 | 10.84M |
| 254 | ACRS | Aclaris Therapeutics, Inc. | 376.26M | 0.65% | 1,426,635 | 7.83M |
| 255 | MNPR | Monopar Therapeutics Inc. | 375.56M | 1.28% | 110,001 | - |
| 256 | BCYC | Bicycle Therapeutics plc | 371.12M | -4.97% | 448,305 | 28.34M |
| 257 | STRO | Sutro Biopharma, Inc. | 368.72M | 5.47% | 220,677 | 105.65M |
| 258 | BNTC | Benitec Biopharma Inc. | 363.10M | -2.84% | 227,007 | - |
| 259 | AURA | Aura Biosciences, Inc. | 361.97M | -7.32% | 261,739 | - |
| 260 | CADL | Candel Therapeutics, Inc. | 355.25M | -2.02% | 1,333,658 | - |
| 261 | CLYM | Climb Bio, Inc. | 352.83M | 1.51% | 723,137 | - |
| 262 | NGNE | Neurogene Inc. | 342.79M | -7.44% | 256,063 | 925.00K |
| 263 | GLSI | Greenwich LifeSciences, Inc. | 341.79M | -8.63% | 117,731 | - |
| 264 | ANL | Adlai Nortye Ltd. | 340.96M | 10.26% | 235,938 | -1.35M |
| 265 | FHTX | Foghorn Therapeutics Inc. | 329.52M | -0.79% | 146,284 | 24.52M |
| 266 | IRD | Opus Genetics, Inc. | 328.96M | 4.38% | 1,713,042 | 14.63M |
| 267 | AVTX | Avalo Therapeutics, Inc. | 325.45M | -4.25% | 1,249,587 | 192.00K |
| 268 | RZLT | Rezolute, Inc. | 325.12M | -4.57% | 1,192,829 | - |
| 269 | RLMD | Relmada Therapeutics, Inc. | 324.87M | -7.13% | 587,415 | - |
| 270 | XFOR | X4 Pharmaceuticals, Inc. | 323.52M | 5.71% | 427,275 | 33.98M |
| 271 | STTK | Shattuck Labs, Inc. | 322.73M | 7.82% | 1,478,015 | 1.00M |
| 272 | IMRX | Immuneering Corporation | 319.62M | -4.26% | 943,002 | - |
| 273 | PBYI | Puma Biotechnology, Inc. | 316.96M | -2.66% | 396,366 | 228.37M |
| 274 | XOMA | XOMA Royalty Corporation | 312.79M | -0.53% | 171,036 | 47.11M |
| 275 | TARA | Protara Therapeutics, Inc. | 311.88M | -6.13% | 782,489 | - |
| 276 | NAUT | Nautilus Biotechnology, Inc. | 308.82M | -6.87% | 203,659 | - |
| 277 | CABA | Cabaletta Bio, Inc. | 306.12M | -7.29% | 1,594,384 | - |
| 278 | CCCC | C4 Therapeutics, Inc. | 295.66M | -1.94% | 2,494,761 | 35.95M |
| 279 | OABI | OmniAb, Inc. | 287.91M | 10.50% | 1,087,313 | 18.67M |
| 280 | HELP | Cybin Inc. | 282.20M | -33.88% | 9,087,595 | - |
| 281 | ALXO | ALX Oncology Holdings Inc. | 281.42M | -2.05% | 340,153 | - |
| 282 | ALDX | Aldeyra Therapeutics, Inc. | 279.85M | -10.49% | 2,544,963 | - |
| 283 | CLLS | Cellectis S.A. | 276.82M | -1.33% | 72,403 | 82.55M |
| 284 | FENC | Fennec Pharmaceuticals Inc. | 270.84M | -3.29% | 240,589 | 38.79M |
| 285 | ACIU | AC Immune SA | 270.11M | -3.87% | 274,035 | 5.48M |
| 286 | ENLV | Enlivex Ltd. | 267.05M | -6.25% | 106,353 | - |
| 287 | SRZN | Surrozen, Inc. | 264.77M | -0.49% | 157,705 | 3.60M |
| 288 | ABEO | Abeona Therapeutics Inc. | 263.91M | -2.01% | 1,797,419 | 400.00K |
| 289 | CHRS | Coherus Oncology, Inc. | 263.07M | - | 1,148,500 | 277.73M |
| 290 | CNTX | Context Therapeutics Inc. | 262.77M | 10.00% | 991,716 | - |
| 291 | IKT | Inhibikase Therapeutics, Inc. | 259.89M | -2.56% | 2,335,105 | 1.00 |
| 292 | SLN | Silence Therapeutics plc | 259.08M | -5.10% | 500,354 | 559.00K |
| 293 | PRLD | Prelude Therapeutics Incorporated | 257.08M | 11.03% | 353,539 | 10.50M |
| 294 | NERV | Minerva Neurosciences, Inc. | 257.05M | -13.03% | 594,373 | - |
| 295 | OBIO | Orchestra BioMed Holdings, Inc. | 253.53M | -1.54% | 128,972 | 2.82M |
| 296 | PALI | Palisade Bio, Inc. | 244.37M | -5.75% | 3,173,878 | - |
| 297 | OVID | Ovid Therapeutics Inc. | 240.84M | 10.12% | 5,294,766 | 6.61M |
| 298 | NVCT | Nuvectis Pharma, Inc. | 239.48M | 0.11% | 59,162 | - |
| 299 | CAMP | Camp4 Therapeutics Corporation | 238.13M | 12.50% | 90,927 | 3.80M |
| 300 | ACHV | Achieve Life Sciences, Inc. | 234.23M | -3.93% | 353,706 | - |
| 301 | KROS | Keros Therapeutics, Inc. | 230.89M | -14.96% | 681,770 | 244.06M |
| 302 | MDWD | MediWound Ltd. | 223.62M | -0.85% | 87,154 | 16.96M |
| 303 | PLX | Protalix BioTherapeutics, Inc. | 223.57M | -1.77% | 1,640,352 | 61.84M |
| 304 | PMN | ProMIS Neurosciences, Inc. | 222.31M | 3.08% | 99,376 | - |
| 305 | ALEC | Alector, Inc. | 220.17M | -7.21% | 1,100,240 | 21.05M |
| 306 | SLGL | Sol-Gel Technologies Ltd. | 220.08M | -10.63% | 37,281 | 18.97M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 218.51M | -4.84% | 647,674 | 31.32M |
| 308 | CBUS | Cibus, Inc. | 217.53M | -3.30% | 315,249 | 3.79M |
| 309 | HUMA | Humacyte, Inc. | 210.37M | -5.22% | 4,436,908 | 1.57M |
| 310 | ELDN | Eledon Pharmaceuticals, Inc. | 207.90M | 4.38% | 980,320 | - |
| 311 | ELTX | Elicio Therapeutics, Inc. | 206.56M | -2.80% | 119,933 | - |
| 312 | ARCT | Arcturus Therapeutics Holdings Inc. | 205.78M | -4.49% | 565,241 | 82.03M |
| 313 | ABOS | Acumen Pharmaceuticals, Inc. | 202.32M | 0.91% | 319,444 | - |
| 314 | GALT | Galectin Therapeutics Inc. | 196.00M | -2.25% | 341,649 | - |
| 315 | HRTX | Heron Therapeutics, Inc. | 192.31M | -9.73% | 3,097,025 | 154.90M |
| 316 | CGEN | Compugen Ltd. | 191.75M | -4.21% | 206,396 | 72.76M |
| 317 | EDIT | Editas Medicine, Inc. | 184.99M | -13.47% | 1,741,808 | 46.38M |
| 318 | MOLN | Molecular Partners AG | 183.80M | -0.09% | 616 | 856.30K |
| 319 | TLSA | Tiziana Life Sciences Ltd | 183.78M | 0.70% | 80,844 | - |
| 320 | NTHI | NeOnc Technologies Holdings, Inc. | 183.64M | -2.08% | 31,253 | 59.99K |
| 321 | SABS | SAB Biotherapeutics, Inc. | 181.38M | -3.05% | 128,329 | 114.70K |
| 322 | KLRS | Kalaris Therapeutics, Inc. | 180.95M | 6.55% | 52,750 | - |
| 323 | RNAC | Cartesian Therapeutics, Inc. | 178.90M | -12.58% | 219,685 | 1.09M |
| 324 | CNTN | Canton Strategic Holdings, Inc. | 177.88M | -3.85% | 778,103 | - |
| 325 | PRQR | ProQR Therapeutics N.V. | 177.51M | -0.88% | 319,893 | 18.86M |
| 326 | TNYA | Tenaya Therapeutics, Inc. | 177.38M | 40.92% | 32,028,191 | - |
| 327 | SGMT | Sagimet Biosciences Inc. | 177.24M | -5.38% | 379,879 | - |
| 328 | TNXP | Tonix Pharmaceuticals Holding Corp. | 175.53M | -1.86% | 303,761 | 10.30M |
| 329 | NKTX | Nkarta, Inc. | 174.73M | -9.89% | 1,011,321 | - |
| 330 | VXRT | Vaxart, Inc. | 173.13M | -5.13% | - | 148.20M |
| 331 | MENS | Jyong Biotech Ltd. | 172.26M | -1.75% | 164,863 | - |
| 332 | WHWK | Whitehawk Therapeutics, Inc. | 168.25M | 9.85% | 170,868 | 14.38M |
| 333 | RANI | Rani Therapeutics Holdings, Inc. | 162.84M | -1.47% | 732,500 | 1.20M |
| 334 | KPTI | Karyopharm Therapeutics Inc. | 161.79M | -3.61% | 509,393 | 146.07M |
| 335 | MIST | Milestone Pharmaceuticals Inc. | 161.52M | -3.64% | 1,301,972 | - |
| 336 | FATE | Fate Therapeutics, Inc. | 159.86M | -5.17% | 1,614,991 | 6.65M |
| 337 | CRBU | Caribou Biosciences, Inc. | 159.83M | -5.00% | 1,085,539 | 9.30M |
| 338 | IPHA | Innate Pharma S.A. | 152.59M | -2.47% | 1,179 | 14.84M |
| 339 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 148.04M | -5.11% | 330,946 | - |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 146.79M | -3.39% | 675,420 | - |
| 341 | IMUX | Immunic, Inc. | 144.82M | -5.13% | 4,219,138 | - |
| 342 | ZNTL | Zentalis Pharmaceuticals, Inc. | 141.48M | -12.95% | 1,448,554 | 26.87M |
| 343 | ARTV | Artiva Biotherapeutics, Inc. | 140.89M | 5.13% | 134,746 | 251.00K |
| 344 | SGMO | Sangamo Therapeutics, Inc. | 140.09M | -4.63% | 2,077,942 | 32.88M |
| 345 | CNTB | Connect Biopharma Holdings Limited | 138.08M | -4.63% | 51,014 | 762.00K |
| 346 | MGNX | MacroGenics, Inc. | 135.37M | 2.88% | 1,006,917 | 127.63M |
| 347 | ORMP | Oramed Pharmaceuticals Inc. | 134.93M | -6.35% | 103,898 | 2.00M |
| 348 | ADAG | Adagene Inc. | 134.80M | -2.39% | 53,186 | 103.20K |
| 349 | SPRO | Spero Therapeutics, Inc. | 129.02M | - | 178,365 | 40.55M |
| 350 | CRDF | Cardiff Oncology, Inc. | 127.84M | -5.56% | 519,360 | 593.00K |
| 351 | AARD | Aardvark Therapeutics, Inc. | 124.98M | 1.77% | 372,863 | - |
| 352 | ACOG | Alpha Cognition Inc. | 124.80M | -2.05% | 85,734 | 7.43M |
| 353 | PLYX | Polaryx Therapeutics, Inc. | 124.04M | -6.09% | 57,710 | - |
| 354 | GOSS | Gossamer Bio, Inc. | 120.77M | -10.03% | 20,539,507 | 44.05M |
| 355 | GNLX | Genelux Corporation | 119.13M | 0.37% | 148,585 | 8.00K |
| 356 | BDTX | Black Diamond Therapeutics, Inc. | 116.80M | -16.67% | 1,574,731 | 70.00M |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 115.42M | -2.89% | 750,711 | 182.34K |
| 358 | CDXS | Codexis, Inc. | 113.81M | 16.67% | 5,457,132 | 52.93M |
| 359 | ONCY | Oncolytics Biotech Inc. | 112.99M | -0.94% | 989,362 | - |
| 360 | COYA | Coya Therapeutics, Inc. | 111.14M | -3.85% | 79,486 | 3.99M |
| 361 | DTIL | Precision BioSciences, Inc. | 109.05M | -5.03% | 161,922 | 698.00K |
| 362 | EQ | Equillium, Inc. | 107.17M | 0.57% | 162,193 | 4.39M |
| 363 | KRRO | Korro Bio, Inc. | 103.92M | -1.03% | 127,453 | 7.37M |
| 364 | SEER | Seer, Inc. | 103.81M | -0.54% | 207,717 | 16.58M |
| 365 | TTRX | Turn Therapeutics Inc. | 99.52M | -1.02% | 5,884 | - |
| 366 | AGEN | Agenus Inc. | 99.30M | -8.75% | 1,010,095 | 106.83M |
| 367 | SAVA | Cassava Sciences, Inc. | 98.55M | -7.69% | 1,291,411 | - |
| 368 | FBIO | Fortress Biotech, Inc. | 97.15M | 0.97% | 303,159 | 62.30M |
| 369 | BMEA | Biomea Fusion, Inc. | 96.86M | -1.44% | 578,064 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 96.80M | -0.34% | 102,976 | - |
| 371 | GANX | Gain Therapeutics, Inc. | 96.54M | -2.33% | 588,652 | - |
| 372 | DWTX | Dogwood Therapeutics, Inc. | 95.23M | -7.44% | 33,967 | - |
| 373 | HURA | TuHURA Biosciences, Inc. | 94.72M | -4.88% | 339,661 | - |
| 374 | KZIA | Kazia Therapeutics Limited | 93.87M | -1.88% | 57,049 | 1.20M |
| 375 | VANI | Vivani Medical, Inc. | 92.23M | -2.12% | 186,400 | - |
| 376 | CGTX | Cognition Therapeutics, Inc. | 91.81M | -1.89% | 497,799 | - |
| 377 | IBIO | iBio, Inc. | 91.20M | -6.71% | 1,590,117 | 300.00K |
| 378 | MAIA | MAIA Biotechnology, Inc. | 89.75M | -1.92% | 966,348 | - |
| 379 | ATYR | aTyr Pharma, Inc. | 88.41M | -6.45% | 1,294,083 | 190.00K |
| 380 | OKYO | OKYO Pharma Limited | 86.56M | 1.51% | 85,263 | - |
| 381 | MCRB | Seres Therapeutics, Inc. | 86.12M | 4.27% | 49,716 | 351.00K |
| 382 | PYXS | Pyxis Oncology, Inc. | 84.06M | -9.40% | 336,871 | 2.82M |
| 383 | VRCA | Verrica Pharmaceuticals Inc. | 83.15M | -2.44% | 58,851 | 30.83M |
| 384 | PMVP | PMV Pharmaceuticals, Inc. | 81.41M | 2.00% | 631,087 | - |
| 385 | PYPD | PolyPid Ltd. | 80.72M | -0.47% | 25,305 | - |
| 386 | CSBR | Champions Oncology, Inc. | 79.57M | -4.50% | 9,556 | 58.42M |
| 387 | PLRX | Pliant Therapeutics, Inc. | 79.27M | - | 211,627 | - |
| 388 | GUTS | Fractyl Health, Inc. | 76.47M | -0.08% | 4,402,407 | 3.00K |
| 389 | ACET | Adicet Bio, Inc. | 75.39M | -1.45% | 77,302 | - |
| 390 | ACTU | Actuate Therapeutics, Inc. | 74.84M | 5.57% | 82,702 | - |
| 391 | PTHS | Pelthos Therapeutics Inc. | 72.51M | -2.61% | 3,092 | 7.41M |
| 392 | XBIT | XBiotech Inc. | 70.43M | -1.70% | 32,553 | - |
| 393 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.15M | -4.85% | 41,579 | 501.00K |
| 394 | CING | Cingulate Inc. | 68.35M | -2.38% | 308,925 | - |
| 395 | IBO | Impact BioMedical Inc. | 67.22M | 55.46% | 204,673,238 | 25.00K |
| 396 | ANVS | Annovis Bio, Inc. | 65.73M | -8.15% | 248,270 | - |
| 397 | IMA | ImageneBio, Inc. | 65.13M | -0.57% | 9,422 | 800.00K |
| 398 | TCRX | TScan Therapeutics, Inc. | 64.13M | 4.63% | 1,010,850 | 10.33M |
| 399 | MNOV | MediciNova, Inc. | 63.99M | -9.72% | 117,957 | 409.66K |
| 400 | QTTB | Q32 Bio Inc. | 63.43M | -4.02% | 159,630 | - |
| 401 | NRXS | NeurAxis, Inc. | 62.64M | 1.20% | 117,142 | 3.36M |
| 402 | EXOZ | eXoZymes, Inc. | 62.50M | 4.94% | 1,024 | -700.00 |
| 403 | IFRX | InflaRx N.V. | 62.33M | 0.51% | 215,347 | 73.73K |
| 404 | MREO | Mereo BioPharma Group plc | 62.22M | -5.58% | 968,081 | 500.00K |
| 405 | ATHE | Alterity Therapeutics Limited | 61.45M | 3.38% | 12,031 | 4.43M |
| 406 | BYSI | BeyondSpring Inc. | 61.27M | -3.25% | 12,877 | 1.88M |
| 407 | MGX | Metagenomi Therapeutics, Inc. | 60.45M | 0.63% | 275,488 | 30.91M |
| 408 | GRCE | Grace Therapeutics, Inc. | 58.18M | -2.84% | 262,888 | - |
| 409 | TIL | Instil Bio, Inc. | 57.85M | -2.63% | 17,092 | - |
| 410 | ICCC | ImmuCell Corporation | 57.44M | -1.70% | 38,238 | 27.64M |
| 411 | SPRB | Spruce Biosciences, Inc. | 57.29M | -6.99% | 37,973 | 697.00K |
| 412 | RLYB | Rallybio Corporation | 57.13M | 2.81% | 210,346 | 674.00K |
| 413 | NRXP | NRx Pharmaceuticals, Inc. | 56.41M | -5.35% | 707,113 | 242.00K |
| 414 | ENTX | Entera Bio Ltd. | 56.40M | -5.38% | 198,927 | 124.00K |
| 415 | HYFT | MindWalk Holdings Corp. | 54.63M | -0.85% | 207,435 | 19.02M |
| 416 | OSTX | OS Therapies Incorporated | 53.17M | 2.72% | 195,391 | - |
| 417 | PSTV | Plus Therapeutics, Inc. | 52.59M | -3.66% | 2,760,881 | 5.26M |
| 418 | RADX | Radiopharm Theranostics Limited | 51.99M | -3.11% | 58,312 | 10.86M |
| 419 | ACRV | Acrivon Therapeutics, Inc. | 50.49M | -5.33% | 736,808 | - |
| 420 | NTRB | Nutriband Inc. | 50.33M | -1.43% | 6,625 | 2.28M |
| 421 | LONA | LeonaBio, Inc. | 50.13M | -10.20% | 121,456 | - |
| 422 | KZR | Kezar Life Sciences, Inc. | 50.02M | -6.57% | 66,119 | - |
| 423 | INKT | MiNK Therapeutics, Inc. | 49.99M | -2.38% | 3,865 | - |
| 424 | ANTX | AN2 Therapeutics, Inc. | 46.86M | 27.61% | 1,537,832 | - |
| 425 | LPCN | Lipocine Inc. | 45.47M | -2.85% | 68,491 | 4.32M |
| 426 | KLTO | Klotho Neurosciences, Inc. | 45.41M | 1.82% | 6,408,498 | - |
| 427 | ESLA | Estrella Immunopharma, Inc. | 45.40M | -0.92% | 32,141 | - |
| 428 | NXTC | NextCure, Inc. | 44.73M | 2.18% | 75,644 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | -2.99% | 37,193 | - |
| 430 | APLM | Apollomics, Inc. | 43.27M | -1.71% | 2,835 | 6.93M |
| 431 | OKUR | OnKure Therapeutics, Inc. | 43.08M | 0.32% | 151,796 | - |
| 432 | LITS | Lite Strategy, Inc. | 41.09M | -7.38% | 291,481 | - |
| 433 | VERU | Veru Inc. | 41.09M | 1.99% | 33,299 | 16.89M |
| 434 | ALGS | Aligos Therapeutics, Inc. | 40.98M | -2.92% | 31,563 | 2.19M |
| 435 | ATOS | Atossa Therapeutics, Inc. | 40.30M | -4.88% | 70,711 | - |
| 436 | PTN | Palatin Technologies, Inc. | 39.87M | 4.57% | 34,425 | 8.96M |
| 437 | XLO | Xilio Therapeutics, Inc. | 39.77M | -0.59% | 296,728 | 31.80M |
| 438 | NBY | NovaBay Pharmaceuticals, Inc. | 38.66M | 1.37% | 152,587 | 10.30M |
| 439 | SNSE | Sensei Biotherapeutics, Inc. | 38.60M | -2.96% | 113,035 | - |
| 440 | JSPR | Jasper Therapeutics, Inc. | 38.34M | -3.52% | 756,873 | - |
| 441 | TVRD | Tvardi Therapeutics, Inc. | 37.71M | - | 80,422 | - |
| 442 | LSTA | Lisata Therapeutics, Inc. | 37.36M | -1.74% | 25,377 | 1.07M |
| 443 | CRVO | CervoMed Inc. | 36.83M | -1.00% | 125,990 | 6.16M |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 36.81M | -4.07% | 155,516 | 90.00K |
| 445 | PDSB | PDS Biotechnology Corporation | 36.14M | -5.66% | 253,343 | - |
| 446 | ATRA | Atara Biotherapeutics, Inc. | 36.05M | -7.24% | 75,819 | 151.93M |
| 447 | OTLK | Outlook Therapeutics, Inc. | 35.87M | -1.53% | 699,242 | 205.70K |
| 448 | CELU | Celularity Inc. | 35.18M | -2.40% | 5,996 | 40.58M |
| 449 | ABVC | ABVC BioPharma, Inc. | 34.96M | -2.35% | 17,419 | 797.92K |
| 450 | INMB | INmune Bio Inc. | 33.63M | -4.17% | 402,623 | 50.00K |
| 451 | PLUR | Pluri Inc. | 33.57M | -6.44% | 3,768 | 1.34M |
| 452 | CVM | CEL-SCI Corporation | 32.37M | 6.95% | 36,113 | - |
| 453 | RNTX | Rein Therapeutics Inc. | 31.81M | 0.83% | 60,471 | - |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 31.26M | -16.70% | 2,149,050 | - |
| 455 | TPST | Tempest Therapeutics, Inc. | 31.14M | -1.28% | 64,065 | - |
| 456 | RNXT | RenovoRx, Inc. | 30.80M | -1.23% | 814,606 | 928.00K |
| 457 | LTRN | Lantern Pharma Inc. | 30.42M | -3.55% | 23,232 | - |
| 458 | HOWL | Werewolf Therapeutics, Inc. | 30.16M | 1.44% | 309,701 | 1.14M |
| 459 | EDSA | Edesa Biotech, Inc. | 30.14M | -15.46% | 1,654,356 | - |
| 460 | BCTX | BriaCell Therapeutics Corp. | 28.92M | -1.47% | 62,078 | - |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 28.53M | -3.91% | 59,246 | - |
| 462 | EVAX | Evaxion A/S | 28.36M | 9.32% | 42,480 | 7.53M |
| 463 | FBLG | FibroBiologics, Inc. | 28.34M | 11.58% | 1,307,206 | - |
| 464 | DYAI | Dyadic International, Inc. | 28.13M | -5.67% | 73,125 | 3.34M |
| 465 | KYNB | Kyntra Bio, Inc. | 27.85M | -0.51% | 8,252 | 8.30M |
| 466 | IGC | IGC Pharma, Inc. | 27.31M | -1.66% | 399,919 | 1.11M |
| 467 | CUE | Cue Biopharma, Inc. | 26.26M | -4.80% | 234,934 | 7.10M |
| 468 | AEON | AEON Biopharma, Inc. | 26.06M | -5.50% | 37,718 | - |
| 469 | HYPD | Hyperion DeFi, Inc. | 26.03M | -3.43% | 120,334 | 345.32K |
| 470 | PASG | Passage Bio, Inc. | 25.81M | -3.79% | 56,001 | - |
| 471 | XCUR | Exicure, Inc. | 25.43M | 11.76% | 33,841 | 500.00K |
| 472 | BOLD | Boundless Bio, Inc. | 25.07M | -1.75% | 54,158 | - |
| 473 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 24.70M | -13.47% | 4,322,106 | - |
| 474 | SNTI | Senti Biosciences, Inc. | 24.66M | -1.50% | 65,026 | - |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 24.47M | -2.16% | 42,680 | 14.99M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 24.34M | 1.54% | 448,775 | 789.00K |
| 477 | BRNS | Barinthus Biotherapeutics plc | 24.13M | -1.52% | 5,124 | 14.97M |
| 478 | SKYE | Skye Bioscience, Inc. | 23.66M | -0.35% | 205,474 | - |
| 479 | IOBT | IO Biotech, Inc. | 23.44M | -1.81% | 296,740 | - |
| 480 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.26M | -4.98% | 19,551 | - |
| 481 | MRKR | Marker Therapeutics, Inc. | 23.18M | -3.47% | 120,034 | 4.69M |
| 482 | DARE | Daré Bioscience, Inc. | 22.43M | 0.64% | 47,093 | -57.13K |
| 483 | PLRZ | Polyrizon Ltd. | 21.69M | 1.11% | 38,329 | - |
| 484 | GNTA | Genenta Science S.p.A. | 21.25M | -0.35% | 20,827 | - |
| 485 | CTXR | Citius Pharmaceuticals, Inc. | 21.23M | 16.19% | 2,294,844 | 3.94M |
| 486 | NNVC | NanoViricides, Inc. | 20.00M | -3.13% | 77,152 | - |
| 487 | INTS | Intensity Therapeutics, Inc. | 19.56M | 0.26% | 18,889 | - |
| 488 | VYNE | VYNE Therapeutics Inc. | 19.41M | -1.75% | 52,500 | 570.00K |
| 489 | LEXX | Lexaria Bioscience Corp. | 19.26M | 9.15% | 95,727 | 522.00K |
| 490 | CVKD | Cadrenal Therapeutics, Inc. | 18.69M | -3.67% | 17,354 | - |
| 491 | KTTA | Pasithea Therapeutics Corp. | 18.38M | -2.91% | 44,335 | - |
| 492 | SER | Serina Therapeutics, Inc. | 16.93M | -5.99% | 70,668 | 116.00K |
| 493 | INAB | IN8bio, Inc. | 16.70M | -1.16% | 18,003 | - |
| 494 | ALLR | Allarity Therapeutics, Inc. | 16.32M | -3.33% | 108,348 | - |
| 495 | HOTH | Hoth Therapeutics, Inc. | 15.59M | -2.43% | 316,735 | - |
| 496 | QNTM | Quantum BioPharma Ltd. | 14.59M | -5.53% | 28,517 | - |
| 497 | JUNS | Jupiter Neurosciences, Inc. | 14.46M | -7.31% | 176,771 | - |
| 498 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.43M | 0.82% | 11,300 | - |
| 499 | CRIS | Curis, Inc. | 13.97M | -0.97% | 140,695 | 11.65M |
| 500 | COCP | Cocrystal Pharma, Inc. | 13.78M | -2.91% | 21,876 | - |
| 501 | KAPA | Kairos Pharma, Ltd. | 13.66M | 4.16% | 258,048 | - |
| 502 | NCEL | NewcelX Ltd. | 13.08M | 1.41% | 4,037 | - |
| 503 | TRAW | Traws Pharma, Inc. | 12.79M | -4.76% | 33,124 | 2.85M |
| 504 | BCDA | BioCardia, Inc. | 12.77M | 1.10% | 29,659 | 3.00K |
| 505 | BLRX | BioLineRx Ltd. | 12.66M | -3.56% | 8,206 | 12.74M |
| 506 | PHIO | Phio Pharmaceuticals Corp. | 12.59M | 1.74% | 641,040 | - |
| 507 | GTBP | GT Biopharma, Inc. | 12.53M | 3.41% | 635,957 | - |
| 508 | BCAB | BioAtla, Inc. | 12.47M | -2.55% | 838,399 | 11.00M |
| 509 | OSRH | OSR Holdings, Inc. | 12.04M | 14.67% | 1,373,253 | -90.52K |
| 510 | GDTC | CytoMed Therapeutics Limited | 12.00M | -1.93% | 4,035 | 573.19K |
| 511 | CLRB | Cellectar Biosciences, Inc. | 11.75M | -4.48% | 36,258 | - |
| 512 | LIMN | Liminatus Pharma, Inc. | 11.71M | 5.67% | 2,215,354 | - |
| 513 | SNGX | Soligenix, Inc. | 11.45M | -2.99% | 115,353 | 2.34K |
| 514 | IMNN | Imunon, Inc. | 11.43M | -2.89% | 19,783 | - |
| 515 | AKTX | Akari Therapeutics, Plc | 11.16M | -1.36% | 210,294 | - |
| 516 | MBRX | Moleculin Biotech, Inc. | 11.05M | -4.27% | 73,857 | - |
| 517 | CMMB | Chemomab Therapeutics Ltd. | 10.89M | -7.33% | 34,347 | - |
| 518 | LGVN | Longeveron Inc. | 10.58M | -5.47% | 493,127 | 1.44M |
| 519 | CALC | CalciMedica, Inc. | 10.41M | 5.93% | 384,440 | - |
| 520 | BIVI | BioVie Inc. | 10.10M | -7.59% | 82,700 | - |
| 521 | CDIO | Cardio Diagnostics Holdings, Inc. | 9.81M | 2.09% | 613,283 | 15.78K |
| 522 | ICU | SeaStar Medical Holding Corporation | 9.30M | 2.79% | 76,829 | 881.00K |
| 523 | PHGE | BiomX Inc. | 9.16M | -8.73% | 107,635 | - |
| 524 | CLGN | CollPlant Biotechnologies Ltd. | 9.14M | 0.75% | 25,715 | 2.48M |
| 525 | ITRM | Iterum Therapeutics plc | 8.84M | -0.71% | 1,359,061 | 390.00K |
| 526 | LNAI | Lunai Bioworks Inc. | 8.74M | -5.12% | 90,640 | - |
| 527 | RNAZ | TransCode Therapeutics, Inc. | 8.56M | -5.18% | 18,107 | - |
| 528 | BOLT | Bolt Biotherapeutics, Inc. | 8.55M | -0.11% | 4,838 | 5.20M |
| 529 | ERNA | Ernexa Therapeutics Inc. | 8.32M | 0.13% | 591,372 | 1,000.00 |
| 530 | NCNA | NuCana plc | 8.16M | -7.98% | 57,695 | - |
| 531 | PULM | Pulmatrix, Inc. | 7.93M | 0.46% | 47,795 | 3.00K |
| 532 | KALA | KALA BIO, Inc. | 7.77M | -20.36% | 2,916,716 | - |
| 533 | TCRT | Alaunos Therapeutics, Inc. | 7.59M | 1.19% | 7,516 | 6.00K |
| 534 | GRDX | GridAI Technologies Corp. | 7.53M | -9.68% | 73,265 | - |
| 535 | ALZN | Alzamend Neuro, Inc. | 7.46M | -1.01% | 39,816 | - |
| 536 | KPRX | Kiora Pharmaceuticals, Inc. | 7.45M | -0.49% | 21,161 | 20.00K |
| 537 | EVGN | Evogene Ltd. | 7.34M | -6.16% | 246,219 | 8.02M |
| 538 | PMCB | PharmaCyte Biotech, Inc. | 6.99M | -6.08% | 79,934 | - |
| 539 | MBIO | Mustang Bio, Inc. | 6.93M | -0.96% | 18,201 | - |
| 540 | ADXN | Addex Therapeutics Ltd | 6.85M | -0.98% | 428 | 198.82K |
| 541 | MLEC | Moolec Science SA | 6.83M | -4.37% | 113,355 | 7.83M |
| 542 | XTLB | XTL Biopharmaceuticals Ltd. | 6.73M | -9.99% | 43,571 | 968.00K |
| 543 | APM | Aptorum Group Limited | 6.72M | -0.15% | 30,350 | - |
| 544 | CELZ | Creative Medical Technology Holdings, Inc. | 6.64M | 2.15% | 11,985 | 6.00K |
| 545 | ASBP | Aspire Biopharma Holdings, Inc. | 6.58M | -0.76% | 118,469 | 1.94K |
| 546 | TOVX | Theriva Biologics, Inc. | 6.58M | -1.39% | 1,472,498 | - |
| 547 | APVO | Aptevo Therapeutics Inc. | 6.50M | -3.27% | 42,726 | - |
| 548 | APRE | Aprea Therapeutics, Inc. | 6.47M | 1.69% | 131,673 | 488.24K |
| 549 | IMRN | Immuron Limited | 6.46M | 8.54% | 88,783 | 4.99M |
| 550 | PCSA | Processa Pharmaceuticals, Inc. | 6.46M | 1.79% | 53,648 | - |
| 551 | CANF | Can-Fite BioPharma Ltd. | 6.45M | -23.59% | 1,003,240 | 560.00K |
| 552 | QNCX | Quince Therapeutics, Inc. | 6.09M | 5.19% | 226,991,540 | - |
| 553 | PPBT | Purple Biotech Ltd | 6.06M | -3.19% | 24,934 | - |
| 554 | REVB | Revelation Biosciences, Inc. | 6.01M | -0.80% | 36,194 | - |
| 555 | PBM | Psyence Biomedical Ltd. | 5.87M | -1.16% | 12,741 | - |
| 556 | CLDI | Calidi Biotherapeutics, Inc. | 5.63M | -3.12% | 31,819 | - |
| 557 | XBIO | Xenetic Biosciences, Inc. | 5.48M | -1.24% | 3,566 | 2.86M |
| 558 | CYCN | Cyclerion Therapeutics, Inc. | 5.37M | 1.50% | 64,813 | 2.86M |
| 559 | SLXN | Silexion Therapeutics Corp | 5.13M | -2.38% | 30,783 | - |
| 560 | MTVA | MetaVia Inc. | 5.10M | -1.24% | 54,113 | - |
| 561 | VIVS | VivoSim Labs, Inc. | 4.88M | - | 44,600 | 142.00K |
| 562 | BGMS | Bio Green Med Solution, Inc. | 4.70M | 0.01% | 5,148 | 81.00K |
| 563 | SILO | Silo Pharma, Inc. | 4.66M | -2.75% | 230,017 | 72.10K |
| 564 | GNPX | Genprex, Inc. | 4.64M | -3.38% | 243,738 | - |
| 565 | GOVX | GeoVax Labs, Inc. | 4.57M | 1.75% | 109,791 | 3.35M |
| 566 | BRTX | BioRestorative Therapies, Inc. | 4.51M | -3.17% | 1,715,140 | 383.40K |
| 567 | INDP | Indaptus Therapeutics, Inc. | 4.26M | -5.47% | 21,284 | - |
| 568 | GLMD | Galmed Pharmaceuticals Ltd. | 4.15M | 7.22% | 31,846 | - |
| 569 | OGEN | Oragenics, Inc. | 3.79M | 3.17% | 191,408 | - |
| 570 | DCOY | Decoy Therapeutics Inc. | 3.72M | -11.34% | 360,226 | - |
| 571 | ACXP | Acurx Pharmaceuticals, Inc. | 3.69M | -4.61% | 75,037 | - |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 3.69M | -4.56% | 8,614 | - |
| 573 | HCWB | HCW Biologics Inc. | 3.63M | -4.08% | 33,309 | 422.03K |
| 574 | GRI | GRI Bio, Inc. | 3.47M | - | 18,979 | - |
| 575 | SPRC | SciSparc Ltd. | 3.14M | 7.34% | 62,360 | 1.31M |
| 576 | DRMA | Dermata Therapeutics, Inc. | 2.89M | 2.54% | 116,439 | - |
| 577 | SCNI | Scinai Immunotherapeutics Ltd. | 2.82M | -4.07% | 21,721 | 1.15M |
| 578 | ENVB | Enveric Biosciences, Inc. | 2.75M | -5.26% | 92,366 | - |
| 579 | JAGX | Jaguar Health, Inc. | 2.73M | -8.03% | 254,311 | 11.79M |
| 580 | PPCB | Propanc Biopharma, Inc. | 2.67M | -2.04% | 767,465 | - |
| 581 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.65M | -9.25% | 74,145 | 1.36M |
| 582 | XRTX | XORTX Therapeutics Inc. | 2.55M | 7.78% | 84,749 | - |
| 583 | ARTL | Artelo Biosciences, Inc. | 2.49M | -2.50% | 7,222 | - |
| 584 | ELAB | PMGC Holdings Inc. | 2.29M | -32.81% | 599,879 | 285.95K |
| 585 | LYRA | Lyra Therapeutics, Inc. | 2.29M | 2.38% | 20,409 | 600.00K |
| 586 | BBLG | Bone Biologics Corporation | 2.19M | -3.20% | 37,781 | - |
| 587 | ADIL | Adial Pharmaceuticals, Inc. | 2.19M | -1.01% | 142,531 | - |
| 588 | ENSC | Ensysce Biosciences, Inc. | 1.96M | 6.73% | 8,857,342 | 4.49M |
| 589 | CMND | Clearmind Medicine Inc. | 1.94M | -9.24% | 89,668 | - |
| 590 | CDT | CDT Equity Inc. | 1.94M | -5.80% | 61,654 | - |
| 591 | AZTR | Azitra, Inc. | 1.89M | -7.07% | 1,378,144 | 7.50K |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 1.86M | -2.60% | 11,274 | - |
| 593 | VRAX | Virax Biolabs Group Limited | 1.54M | -0.96% | 137,673 | 2.99K |
| 594 | ONCO | Onconetix, Inc. | 886.36K | -15.52% | 487,484 | 1.22M |
| 595 | BDRX | Biodexa Pharmaceuticals Plc | 794.67K | 0.79% | 41,790 | 104.90K |
| 596 | ADTX | Aditxt, Inc. | 770.62K | -8.58% | 315,428 | 5.95K |